Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J Perkins

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Psychoneuroendocrinology|November 21, 2019
Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorderAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
Infection and Immunity|November 4, 2009
A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemiaCollins Ouma, Christopher C Keller, Gregory C Davenport, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2006
Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young childrenCollins Ouma, Christopher C Keller, Dorothy A Opondo, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Virtual and <i>In Vitro</i> Antiviral Screening Revive Therapeutic Drugs for COVID-19Giovanni Bocci, Steven B Bradfute, Chunyan Ye, et al.
Human Genetics|August 6, 2011
Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan childrenCollins Ouma, Gregory C Davenport, Steven Garcia, et al.
JMIR Public Health and Surveillance|January 27, 2025
Effectiveness of Frequent Point-of-Care Molecular COVID-19 Surveillance in a Rural Workplace: Nonrandomized Controlled Clinical Trial Among MinersAkshay Sood, William Cotton Jarrell, Xin W Shore, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
Transcriptomic and Proteomic Insights into Host Immune Responses in Pediatric Severe Malarial Anemia: Dysregulation in HSP60-70-TLR2/4 Signaling and Altered Glutamine MetabolismClinton O Onyango, Samuel B Anyona, Ivy Hurwitz, et al.
Scientific Reports|April 15, 2025
Impact of age, HIV1, sickle-cell genotypes, and interferon-gamma gene upstream variants on malaria disease outcomes in a longitudinal pediatric cohortEvans Raballah, Samuel B Anyona, Shamim W Osata, et al.
Ebiomedicine|July 7, 2019
Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan childrenAngela O Achieng, Nicolas W Hengartner, Evans Raballah, et al.
JMIR Mental Health|March 10, 2021
Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness StudyAnastasiya Nestsiarovich, Praveen Kumar, Nicolas Raymond Lauve, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Psychoneuroendocrinology|November 21, 2019
Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorderAnastasiya Nestsiarovich, Berit Kerner, Aurélien J Mazurie, et al.
Infection and Immunity|November 4, 2009
A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemiaCollins Ouma, Christopher C Keller, Gregory C Davenport, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2006
Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young childrenCollins Ouma, Christopher C Keller, Dorothy A Opondo, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Virtual and <i>In Vitro</i> Antiviral Screening Revive Therapeutic Drugs for COVID-19Giovanni Bocci, Steven B Bradfute, Chunyan Ye, et al.
Human Genetics|August 6, 2011
Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan childrenCollins Ouma, Gregory C Davenport, Steven Garcia, et al.
JMIR Public Health and Surveillance|January 27, 2025
Effectiveness of Frequent Point-of-Care Molecular COVID-19 Surveillance in a Rural Workplace: Nonrandomized Controlled Clinical Trial Among MinersAkshay Sood, William Cotton Jarrell, Xin W Shore, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
Transcriptomic and Proteomic Insights into Host Immune Responses in Pediatric Severe Malarial Anemia: Dysregulation in HSP60-70-TLR2/4 Signaling and Altered Glutamine MetabolismClinton O Onyango, Samuel B Anyona, Ivy Hurwitz, et al.
Scientific Reports|April 15, 2025
Impact of age, HIV1, sickle-cell genotypes, and interferon-gamma gene upstream variants on malaria disease outcomes in a longitudinal pediatric cohortEvans Raballah, Samuel B Anyona, Shamim W Osata, et al.
Ebiomedicine|July 7, 2019
Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan childrenAngela O Achieng, Nicolas W Hengartner, Evans Raballah, et al.
JMIR Mental Health|March 10, 2021
Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness StudyAnastasiya Nestsiarovich, Praveen Kumar, Nicolas Raymond Lauve, et al.
Pageof 10